Alimta and Omental infarction - a phase IV clinical study of FDA data
Summary:
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Alimta?
Alimta has active ingredients of pemetrexed disodium. Currently, eHealthMe is studying from 7,702 Alimta users.
What is Omental Infarction?
Omental infarction (a rare cause of acute abdomen resulting from less vascular supply of the greater omentum abdominal muscle) is found to be associated with 33 drugs and 22 conditions by eHealthMe. Currently, we are studying 44 people who have Omental infarction.
Do you take Alimta and have Omental infarction?
Check whether Omental infarction is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alimta side effects by duration, gender and age:
- Alimta side effects (7,702 reports)
Omental infarction treatments and more:
- Omental infarction (44 reports)
All the drugs that are associated with Omental infarction:
All the conditions that are associated with Omental infarction:
How the study uses the data?
The study uses data from the FDA. It is based on pemetrexed disodium (the active ingredients of Alimta) and Alimta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hydroxyurea and Cardio-Respiratory Arrest - a second ago
- Lisinopril And Hydrochlorothiazide and Death - 13 seconds ago
- Byetta and Atelectasis - 19 seconds ago
- Voltaren and Blood Glucose Fluctuation - 20 seconds ago
- Requip and Face Injury - 20 seconds ago
- Pantoprazole and Temovate drug interaction - 21 seconds ago
- Guaifenesin and Uveitis - 22 seconds ago
- Imbruvica and Herpes Zoster - 25 seconds ago
- Miralax and Aripiprazole drug interaction - 31 seconds ago
- Januvia and Immunosuppressant Drug Level Increased - 43 seconds ago